Drug recall: Cipla recalls over 1.8k boxes of this drug

While the drug recall is undoubtedly a setback for Cipla, it's important to note that the company has taken proactive steps to address the issue.

321
Drug recall
Drug recall

Last Updated on November 30, 2024 by The Health Master

Drug recall

Cipla, a leading pharmaceutical company based in India, has initiated a voluntary drug recall of over 1,800 boxes of Lanthanum Carbonate chewable tablets in the United States.

This drug recall, categorized as a Class II drug recall by the US Food and Drug Administration (USFDA), was prompted by consumer complaints regarding crushed and broken tablets.

Why the Drug Recall?

A Class II drug recall is issued when the use of a defective product could potentially lead to temporary or reversible health issues, or when the risk of serious adverse health consequences is minimal.

In this case, Cipla USA, Inc., the US-based subsidiary of Cipla, determined that the quality of the affected lot of Lanthanum Carbonate did not meet the required standards.

Impact on Patients and the Company

While the drug recall is undoubtedly a setback for Cipla, it’s important to note that the company has taken proactive steps to address the issue.

The drug recall is limited to a specific lot of the medication, and patients who have purchased the affected product are advised to contact their healthcare provider or return the medication to the pharmacy.

India’s Role in Global Pharmaceutical Supply

India has emerged as a global pharmaceutical powerhouse, supplying generic drugs to over 200 countries.

The nation’s robust pharmaceutical industry, coupled with its skilled workforce and cost-effective manufacturing processes, has positioned it as a major player in the global healthcare market.

Key Takeaways

  • Cipla has initiated a voluntary drug recall of Lanthanum Carbonate tablets in the US.
  • The drug recall is due to quality issues related to tablet integrity.
  • India is a major global supplier of generic drugs.
  • The drug recall highlights the importance of quality control in the pharmaceutical industry.

By addressing quality concerns promptly and transparently, Cipla aims to maintain its reputation as a reliable provider of affordable medications.

  1. What is Lanthanum Carbonate used for?

    Lanthanum Carbonate is a medication prescribed to manage high phosphate levels in the blood, particularly in patients with chronic kidney disease.

  2. Why is a Class II drug recall issued?

    A Class II drug recall is issued when there is a potential for temporary or reversible adverse health consequences.

  3. What should patients do if they have purchased the affected product?

    Patients should contact their healthcare provider or return the medication to the pharmacy.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.

Disclaimer: This content, provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. The Health Master does not claim responsibility for this information.

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news